Transarterial chemoembolization with miriplatin vs. epirubicin for unresectable hepatocellular carcinoma: a phase III randomized trial

Prospective Study of Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: An Asian Cooperative Study between Japan and Korea

(2013) Masafumi Ikeda et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Transarterial Chemoembolization for Hepatocellular Carcinoma over Three Decades: Current Progress and Perspective

(2012) K. Takayasu   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version

(2011) Masatoshi Kudo et al.   DIGESTIVE DISEASES

A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma

(2011) Takuji Okusaka et al.   INVESTIGATIONAL NEW DRUGS

Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase III trial

(2009) Takuji Okusaka et al.   JOURNAL OF HEPATOLOGY

Intra-hepatic arterial administration with miriplatin suspended in an oily lymphographic agent inhibits the growth of human hepatoma cells orthotopically implanted in nude rats

(2008) Mitsuharu Hanada et al.   CANCER SCIENCE